342 A phase 1/2 study evaluating the safety, pharmacokinetics and efficacy of ABT-414 in subjects with advanced solid tumors likely to over-express the epidermal growth factor receptor (EGFR)

Saved in:
Bibliographic Details
Published inEuropean journal of cancer (1990) Vol. 50; p. 111
Main Authors Tolcher, A., Goss, G., Gordon, M., Gandhi, L., Papadopoulos, K.P., Rasco, D., Pedersen, M., Fischer, J., Ames, W., Xiong, H., Dudley, M., Munasinghe, W., Ansell, P., Holen, K., Vokes, E.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.11.2014
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

More Information
ISSN:0959-8049
1879-0852
DOI:10.1016/S0959-8049(14)70468-X